Description:
OSTEOGENESIS IMPERFECTA, TYPE I; OI1
COLLAGEN, TYPE I, ALPHA-1; COL1A1
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of Connective Tissue, Muscle, and Bone |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
White
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
7 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase Isoenzyme Electrophoresis |
|
GENE MAPPING & DOSAGE STUDIES - Y CHROMOSOME |
PCR analysis of DNA from this cell culture gave a positive result with a primer for Yq11, DYS227. |
|
Gene |
COL1A1 |
Chromosomal Location |
17q21.33 |
Allelic Variant 1 |
; OSTEOGENESIS IMPERFECTA, TYPE I; OI1 |
Identified Mutation |
c.1273G>A (p.Gly425Ser) |
Remarks |
Colombian; blue sclerae; pliable skull; poor mineralization of skull & short, thick, ribbon-like poorly mineralized long bones; multiple fractures; normal serum phosphoethanolamine |
Mackay K, Byers PH, Dalgleish R, An RT-PCR-SSCP screening strategy for detection of mutations in the gene encoding the alpha 1 chain of type I collagen: application to four patients with osteogenesis imperfecta. Hum Mol Genet2:1155-60 1993 |
PubMed ID: 7691343 |
Passage Frozen |
7 |
Split Ratio |
1:5 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|